Abbott Laboratories




Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2023-12-08 pm EST Intraday chart for Abbott Laboratories 5-day change 1st Jan Change
104.51 USD +0.44% -0.35% -4.81%
This article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
NeuroOne Medical Technologies Names Christopher Volker as Chief Operating Officer MT
Wall Street wavers after rally, focus on inflation data RE
Abbott Laboratories' Clinical Trial for Patients With HeartMate 3 Heart Pump Meets Primary Endpoint MT
Medical device stocks rise in relief after Wegovy heart benefits data RE
Medical device makers rise on relief after Wegovy obesity trial data RE
Wall St falls as megacaps drag ahead of inflation data RE
Abbott Announces New Late-Breaking Data That Show Advanced Heart Failure Patients Living with its HeartMate 3 Heart Pump CI
Corporate America weighs business impact of new weight-loss drugs RE
BD forecasts full-year profit below estimates on China headwinds RE
Abbott India's Q2 profit climbs on strong sales RE
Corporate America weighs business impact of new weight-loss drugs RE
Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes CI
Zimmer Biomet beats quarterly profit estimates on knee procedure strength RE
Abbott Laboratories Says FDA Approves HPV Screening, Assessment Tool MT
Abbott Laboratories Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV CI
Stereotaxis Says First US Arrhythmia Patients Treated with Robotic Navigation and Abbott's Cardiac Mapping System MT
GE HealthCare beats quarterly profit estimates on imaging device demand RE
Abbott Laboratories Insider Sold Shares Worth $4,702,526, According to a Recent SEC Filing MT
Dexcom lifts 2023 revenue view on strong demand for diabetes devices RE
Corporate America weighs business impact of new weight-loss drugs RE
Abbott to cease sale of infant probiotic products after FDA warning RE
FDA Warns Abbott, Infinant Health About Selling Preterm Infant Probiotic Products DJ
Edwards Lifesciences quarterly sales jump on robust demand for heart devices RE
Abbott Laboratories' Discloses Temporary Implant Benefits in Patients With Artery Disease MT
Abbott Laboratories to Submit Limb-Threatening Ischemia Drug to FDA Review DJ
Chart Abbott Laboratories
More charts
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (38%); - vascular devices (21%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (17.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (11.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (12.7%). Net sales are distributed geographically as follows: the United States (41.5%), Germany (5.4%), China (4.9%), Japan (4.4%), India (3.8%), Switzerland (3.1%), Canada (2.9%) and other (34%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
More Ratings
Mean consensus
Number of Analysts
Last Close Price
Average target price
Spread / Average Target
  1. Stock
  2. Equities
  3. Stock Abbott Laboratories - Nyse
  4. News Abbott Laboratories
  5. Earnings Flash (ABT) ABBOTT Posts Q1 EPS $1.03, vs. Street Est of $0.98
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits